SCHEMBL19459509

SCHEMBL19459509

CSc1nc(N)c2ncn(C3[C@H]4OC(C)(C)O[C@H]4[C@]4(CP=O)C[C@H]34)c2n1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ P2RY1 P47900 8/20 0.53
▸ ADORA3 P0DMS8 6/20 0.45
▸ ADORA1 P30542 3/20 0.45
▸ HSP90AA1 P07900 1/20 0.40
▸ HSP90B1 P14625 1/20 0.40
▸ ADORA2A P29274 1/20 0.40
▸ TMEM97 Q5BJF2 1/20 0.40
▸ SIGMAR1 Q99720 1/20 0.40
▸ HRH2 P25021 1/20 0.38
▸ HTR5A P47898 1/20 0.38
▸ HTR2B P41595 2/20 0.38
▸ ADRA2B P18089 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ HTR2C P28335 1/20 0.38
▸ ENPP1 P22413 1/20 0.37
▸ P2RY12 Q9H244 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19799167 1.00 P2RY1 (0.53) P2RY1ADORA3ADORA1HSP90AA1HSP90B1
SCHEMBL19459536 0.88 ADORA3 (0.54) P2RY1ADORA3ADORA1HSP90AA1HSP90B1
SCHEMBL19799169 0.88 ADORA3 (0.54) P2RY1ADORA3ADORA1HSP90AA1HSP90B1
SCHEMBL19464887 0.87 P2RY1 (0.54) P2RY1ADORA3ADORA1HSP90AA1HSP90B1
SCHEMBL19799166 0.80 HRH2 (0.49) P2RY1ADORA3ADORA1HSP90AA1HSP90B1
SCHEMBL19459932 0.80 HRH2 (0.49) P2RY1ADORA3ADORA1HSP90AA1HSP90B1
SCHEMBL31350113 0.79 ADORA3 (0.69) P2RY1ADORA3ADORA1HSP90AA1HSP90B1
SCHEMBL31350197 0.77 ADORA3 (0.66) P2RY1ADORA3ADORA1HSP90AA1HSP90B1
SCHEMBL12269824 0.76 ADORA3 (0.66) P2RY1ADORA3ADORA1HSP90AA1HSP90B1
SCHEMBL12269821 0.76 ADORA3 (0.56) P2RY1ADORA3ADORA1HSP90AA1HSP90B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9789131-B1 Compounds and methods for treating neurological and cardiovascular conditions ASTROCYTE PHARMACEUTICALS, INC. (US) 2017-10-17 — — US disclosed
Send feedback